Researcher Profiles

Return to member profile

Deborah L. Toppmeyer, MD

Publications since 2011

Sparano, J. A. Gray, R. J. Makower, D. F. Pritchard, K. I. Albain, K. S. Hayes, D. F. Geyer, C. E. Jr Dees, E. C. Perez, E. A. Olson, J. A. Jr Zujewski, J. Lively, T. Badve, S. S. Saphner, T. J. Wagner, L. I. Whelan, T. J. Ellis, M. J. Paik, S. Wood, W. C. Ravdin, P. Keane, M. M. Gomez Moreno, H. L. Reddy, P. S. Goggins, T. F. Mayer, I. A. Brufsky, A. M. Toppmeyer, D. L. Kaklamani, V. G. Atkins, J. N. Berenberg, J. L. Sledge, G. W. Prospective Validation of a 21-Gene Expression Assay in Breast Cancer. N Engl J Med, In process, . (PMID: 26412349)

Rugo, H. S. Barry, W. T. Moreno-Aspitia, A. Lyss, A. P. Cirrincione, C. Leung, E. Mayer, E. L. Naughton, M. Toppmeyer, D. Carey, L. A. Perez, E. A. Hudis, C. Winer, E. P. Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab as First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NCCTG N063H (Alliance). J Clin Oncol, In process, . (PMID: 26056183)

Kaufman, S. A. Harris, E. E. Bailey, L. Chadha, M. Dutton, S. C. Freedman, G. M. Goyal, S. Halyard, M. Y. Horst, K. C. Novick, K. L. Park, C. C. Suh, W. W. Toppmeyer, D. Zook, J. Haffty, B. G. ACR Appropriateness Criteria(R) Ductal Carcinoma in Situ. Oncology (Williston Park), 29:446-58, 460, . (PMID: 26089220)

Halyard, M. Y. Harris, E. E. Bailey, L. Bellon, J. R. Freedman, G. M. Goyal, S. Horst, K. C. Moran, M. S. Park, C. C. Suh, W. W. Toppmeyer, D. Haffty, B. G. ACR Appropriateness Criteria local-regional recurrence (LRR) and salvage surgery-breast cancer. Oncology (Williston Park), 28:157-64, C3, . (PMID: 24701707)

Chojecki, A. Wong, S. Toppmeyer, D. Optimal management of the premenopausal patient with estrogen receptor-positive breast cancer. Am Soc Clin Oncol Educ Book, :e12-e15, . (PMID: 24857090)

Tian, S. Hirshfield, K. M. Jabbour, S. K. Toppmeyer, D. Haffty, B. G. Khan, A. J. Goyal, S. Serum biomarkers for the detection of cardiac toxicity after chemotherapy and radiation therapy in breast cancer patients. Front Oncol, 4:277, . (PMID: 25346912, PMCID: PMC4191171)

Mehta, M. S. Dolfi, S. C. Bronfenbrener, R. Bilal, E. Chen, C. Moore, D. Lin, Y. Rahim, H. Aisner, S. Kersellius, R. D. Teh, J. Chen, S. Toppmeyer, D. L. Medina, D. J. Ganesan, S. Vazquez, A. Hirshfield, K. M. Metabotropic glutamate receptor 1 expression and its polymorphic variants associate with breast cancer phenotypes. PLoS One, 8:e69851, . (PMID: 23922822, PMCID: PMC3724883)

Bilal, E. Vassallo, K. Toppmeyer, D. Barnard, N. Rye, I. H. Almendro, V. Russnes, H. Borresen-Dale, A. L. Levine, A. J. Bhanot, G. Ganesan, S. Amplified Loci on Chromosomes 8 and 17 Predict Early Relapse in ER-Positive Breast Cancers. PLoS One, 7:e38575, . (PMID: 22719901, PMCID: PMC3374812)

Vazquez, A. Kulkarni, D. Grochola, L. F. Bond, G. L. Barnard, N. Toppmeyer, D. Levine, A. J. Hirshfield, K. M. A genetic variant in a PP2A regulatory subunit encoded by the PPP2R2B gene associates with altered breast cancer risk and recurrence. Int J Cancer, 128:2335-2343, . (PMID: 20669227)

Mehta, M. S. Vazquez, A. Kulkarni, D. A. Kerrigan, J. E. Atwal, G. Metsugi, S. Toppmeyer, D. L. Levine, A. J. Hirshfield, K. M. Polymorphic variants in TSC1 and TSC2 and their association with breast cancer phenotypes. Breast Cancer Res Treat, 125:861-868, . (PMID: 20658316)